No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO Annual Meeting. This abstract does not include a full text component.

RAINFALL: A randomized, double-blind, placebo-controlled phase III study of cisplatin (Cis) plus capecitabine (Cape) or 5FU with or without ramucirumab (RAM) as first-line therapy in patients with ...

The mean cost for robot-assisted minimally invasive thoraco-laparoscopic esophagectomy appeared lower than those of open transthoracic esophagectomy (34.892 euros vs. 39.463 euros; P = .07).